83_FR_31894 83 FR 31763 - Waterway Suitability Assessment for Operation of Liquefied Natural Gas Terminal; Cameron, LA

83 FR 31763 - Waterway Suitability Assessment for Operation of Liquefied Natural Gas Terminal; Cameron, LA

DEPARTMENT OF HOMELAND SECURITY
Coast Guard

Federal Register Volume 83, Issue 131 (July 9, 2018)

Page Range31763-31764
FR Document2018-14596

We are requesting your comments on a Letter of Intent and Preliminary Waterway Suitability Assessment we received from Sabine Pass LNG, L.P. (SPLNG) regarding SPLNG's plans to construct a new berth at its Cameron Parish, LA facility and to increase the number of liquefied natural gas vessels calling at the facility from approximately 400 to 580 annually. The Coast Guard is notifying the public of this proposed increase in LNG marine traffic on the Sabine- Neches Waterway and is soliciting comments relevant to the Coast Guard's preparation of a Letter of Recommendation for issuance to the federal, state, or local agency with jurisdiction over the proposed facility.

Federal Register, Volume 83 Issue 131 (Monday, July 9, 2018)
[Federal Register Volume 83, Number 131 (Monday, July 9, 2018)]
[Notices]
[Pages 31763-31764]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-14596]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2017-0915]


Waterway Suitability Assessment for Operation of Liquefied 
Natural Gas Terminal; Cameron, LA

AGENCY: Coast Guard, DHS.

ACTION: Notice of inquiry; request for comments.

-----------------------------------------------------------------------

SUMMARY: We are requesting your comments on a Letter of Intent and 
Preliminary Waterway Suitability Assessment we received from Sabine 
Pass LNG, L.P. (SPLNG) regarding SPLNG's plans to construct a new berth 
at its Cameron Parish, LA facility and to increase the number of 
liquefied natural gas vessels calling at the facility from 
approximately 400 to 580 annually. The Coast Guard is notifying the 
public of this proposed increase in LNG marine traffic on the Sabine-
Neches Waterway and is soliciting comments relevant to the Coast 
Guard's preparation of a Letter of Recommendation for issuance to the 
federal, state, or local agency with jurisdiction over the proposed 
facility.

DATES: Comments and related material must be received on or before 
August 8, 2018.

ADDRESSES: You may submit comments identified by docket number USCG-
2017-0915 using the Federal eRulemaking Portal at http://www.regulations.gov. See the ``Public Participation and Request for 
Comments'' portion of the SUPPLEMENTARY INFORMATION section below for 
further instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: If you have questions about this 
notice of inquiry, call or email Mr. Scott K. Whalen, Vessel Traffic 
Service Director, Marine Safety Unit Port Arthur, U.S. Coast Guard; 
telephone 409-719-5086, email [email protected].

SUPPLEMENTARY INFORMATION:

I. Table of Abbreviations

CFR Code of Federal Regulations
COTP Captain of the Port Marine Safety Unit Port Arthur
DHS Department of Homeland Security
LNG Liquefied Natural Gas
LOI Letter of Intent
LOR Letter of Recommendation
NVIC Navigation and Vessel Inspection Circular
U.S.C. United States Code
WSA Waterway Suitability Assessment

II. Background and Purpose

    Under 33 CFR 127.007(a), an owner or operator planning to build a 
new facility handling liquefied natural gas (LNG), or an owner or 
operator planning new construction to expand or modify marine terminal 
operations in an existing facility handling LNG, where the 
construction, expansion, or modification would result in an increase in 
the size and/or frequency of LNG marine traffic on the waterway 
associated with the proposed facility or modification to an existing 
facility, must submit a Letter of Intent (LOI) to the Captain of the 
Port of the zone in which the facility is or will be located. Under 33 
CFR 127.007(e), an owner or operator planning such new construction or 
expansion of an existing facility must also file or update a Waterway 
Suitability Assessment (WSA) that addresses the proposed increase in 
LNG marine traffic in the associated waterway.
    Under 33 CFR 127.009, after receiving an LOI, the Captain of the 
Port issues a Letter of Recommendation (LOR) as to the suitability of 
the waterway for LNG marine traffic to the appropriate jurisdictional 
authorities. The LOR is based on a series of factors listed in 33 CFR 
127.009 that relate to the physical nature of the affected waterway and 
issues of safety and security associated with LNG marine traffic on the 
affected waterway.

III. Information Requested

    On January 29, 2018, Sabine Pass LNG, L.P. (SPLNG), located in 
Cameron Parish, LA, submitted an LOI and Preliminary WSA regarding the 
company's proposed plans to develop a new marine berth and expand the 
number of vessels calling on the facility each year from approximately 
400 to 580. The purpose of this notice is to solicit public comments on 
the proposed increase in LNG marine traffic on the Sabine-Neches 
Waterway. The Coast Guard believes that public input may be useful to 
the Captain of the Port Marine Safety Unit Port Arthur (COTP) with 
respect to validating the information provided in SPLNG's Preliminary 
WSA and development of the LOR. A brief summary of SPLNG's proposal is 
available in the docket where indicated under ADDRESSES.
    On January 24, 2011, the Coast Guard published Navigation and 
Vessel Inspection Circular (NVIC) 01-2011, titled ``Guidance Related to 
Waterfront Liquefied Natural Gas (LNG) Facilities''. NVIC 01-2011 
provides guidance for owners and operators seeking approval to build 
and operate LNG facilities. The

[[Page 31764]]

Coast Guard will refer to NVIC 01-2011 for process information and 
guidance in evaluating SPLNG's WSA. NVIC 01-2011 is available in the 
docket where indicated under ADDRESSES and also on the Coast Guard's 
website at https://www.dco.uscg.mil/Portals/9/DCO%20Documents/5p/5ps/NVIC/2011/NVIC%2001-2011%20Final.pdf.

IV. Public Participation and Request for Comments

    We encourage you to submit comments through the Federal portal at 
http://www.regulations.gov. If your material cannot be submitted using 
http://www.regulations.gov, contact the person in the FOR FURTHER 
INFORMATION CONTACT section of this document for alternate 
instructions. In your submission, please include the docket number for 
this notice of inquiry and provide a reason for each suggestion or 
recommendation.
    We accept anonymous comments. All comments received will be posted 
without change to http://www.regulations.gov and will include any 
personal information you have provided. For more about privacy and the 
docket, visit http://www.regulations.gov/privacyNotice.
    Documents mentioned in this notice of inquiry as being available in 
the docket, and all public comments, will be in our online docket at 
http://www.regulations.gov and can be viewed by following that 
website's instructions.
    This document is issued under authority of 5 U.S.C. 552 (a).

    Dated: July 2, 2018.
Jacqueline Twomey,
Captain, U.S. Coast Guard, Captain of the Port Marine Safety Unit Port 
Arthur.
[FR Doc. 2018-14596 Filed 7-6-18; 8:45 am]
 BILLING CODE 9110-04-P



                                                                                 Federal Register / Vol. 83, No. 131 / Monday, July 9, 2018 / Notices                                            31763

                                                limitations imposed by the review and                    DEPARTMENT OF HOMELAND                                II. Background and Purpose
                                                funding cycle.                                           SECURITY                                                 Under 33 CFR 127.007(a), an owner or
                                                   Name of Committee: National Institute of                                                                    operator planning to build a new facility
                                                Diabetes and Digestive and Kidney Diseases               Coast Guard
                                                                                                                                                               handling liquefied natural gas (LNG), or
                                                Special Emphasis Panel; Mechanisms and                   [Docket No. USCG–2017–0915]                           an owner or operator planning new
                                                Treatments of Lower Urinary Tract
                                                                                                                                                               construction to expand or modify
                                                Dysfunction after Spinal Cord Injury.                    Waterway Suitability Assessment for                   marine terminal operations in an
                                                   Date: July 23, 2018.                                  Operation of Liquefied Natural Gas                    existing facility handling LNG, where
                                                   Time: 1:00 p.m. to 4:00 p.m.                          Terminal; Cameron, LA                                 the construction, expansion, or
                                                   Agenda: To review and evaluate grant
                                                applications.                                                  Coast Guard, DHS.
                                                                                                         AGENCY:                                               modification would result in an increase
                                                   Place: National Institutes of Health, Two                                                                   in the size and/or frequency of LNG
                                                                                                               Notice of inquiry; request for
                                                                                                         ACTION:
                                                Democracy Plaza, 6707 Democracy                                                                                marine traffic on the waterway
                                                                                                         comments.
                                                Boulevard, Bethesda, MD 20892 (Telephone                                                                       associated with the proposed facility or
                                                Conference Call).                                        SUMMARY:    We are requesting your                    modification to an existing facility, must
                                                   Contact Person: Paul A. Rushing, Ph.D.,               comments on a Letter of Intent and                    submit a Letter of Intent (LOI) to the
                                                Scientific Review Officer, Review Branch,                Preliminary Waterway Suitability                      Captain of the Port of the zone in which
                                                DEA, NIDDK, National Institutes of Health,               Assessment we received from Sabine                    the facility is or will be located. Under
                                                Room 7345, 6707 Democracy Boulevard,                     Pass LNG, L.P. (SPLNG) regarding                      33 CFR 127.007(e), an owner or operator
                                                Bethesda, MD 20892–5452, (301) 594–8895,                 SPLNG’s plans to construct a new berth                planning such new construction or
                                                rushingp@extra.niddk.nih.gov.                            at its Cameron Parish, LA facility and to             expansion of an existing facility must
                                                   Name of Committee: National Institute of              increase the number of liquefied natural              also file or update a Waterway
                                                Diabetes and Digestive and Kidney Diseases               gas vessels calling at the facility from              Suitability Assessment (WSA) that
                                                Special Emphasis Panel; Urologic P20                     approximately 400 to 580 annually. The                addresses the proposed increase in LNG
                                                Applications.                                            Coast Guard is notifying the public of                marine traffic in the associated
                                                   Date: August 2–3, 2018.                               this proposed increase in LNG marine                  waterway.
                                                   Time: 8:00 a.m. to 1:00 p.m.                          traffic on the Sabine-Neches Waterway                    Under 33 CFR 127.009, after receiving
                                                   Agenda: To review and evaluate grant                  and is soliciting comments relevant to                an LOI, the Captain of the Port issues a
                                                applications.                                            the Coast Guard’s preparation of a Letter             Letter of Recommendation (LOR) as to
                                                   Place: Embassy Suites at the Chevy Chase              of Recommendation for issuance to the                 the suitability of the waterway for LNG
                                                Pavilion, 4300 Military Road NW,                         federal, state, or local agency with                  marine traffic to the appropriate
                                                Washington, DC 20015.                                    jurisdiction over the proposed facility.              jurisdictional authorities. The LOR is
                                                   Contact Person: Ryan G. Morris, Ph.D.,                                                                      based on a series of factors listed in 33
                                                                                                         DATES: Comments and related material
                                                Scientific Review Officer, Review Branch,                                                                      CFR 127.009 that relate to the physical
                                                DEA, NIDDK, National Institutes of Health,               must be received on or before August 8,
                                                                                                         2018.                                                 nature of the affected waterway and
                                                Room 7015, 6707 Democracy Boulevard,                                                                           issues of safety and security associated
                                                Bethesda, MD 20892–2542, 301–594–4721,                   ADDRESSES: You may submit comments
                                                                                                                                                               with LNG marine traffic on the affected
                                                ryan.morris@nih.gov.                                     identified by docket number USCG–
                                                                                                                                                               waterway.
                                                   Name of Committee: National Institute of              2017–0915 using the Federal
                                                Diabetes and Digestive and Kidney Diseases               eRulemaking Portal at http://                         III. Information Requested
                                                Special Emphasis Panel; Diabetes Ancillary               www.regulations.gov. See the ‘‘Public                    On January 29, 2018, Sabine Pass
                                                Studies (R01).                                           Participation and Request for                         LNG, L.P. (SPLNG), located in Cameron
                                                   Date: August 2, 2018.                                 Comments’’ portion of the                             Parish, LA, submitted an LOI and
                                                   Time: 1:30 p.m. to 4:30 p.m.                          SUPPLEMENTARY INFORMATION section                     Preliminary WSA regarding the
                                                   Agenda: To review and evaluate grant                  below for further instructions on                     company’s proposed plans to develop a
                                                applications.                                            submitting comments.                                  new marine berth and expand the
                                                   Place: National Institutes of Health, Two             FOR FURTHER INFORMATION CONTACT: If                   number of vessels calling on the facility
                                                Democracy Plaza, 6707 Democracy                          you have questions about this notice of               each year from approximately 400 to
                                                Boulevard, Bethesda, MD 20892 (Telephone                 inquiry, call or email Mr. Scott K.                   580. The purpose of this notice is to
                                                Conference Call).                                        Whalen, Vessel Traffic Service Director,
                                                   Contact Person: Ann A. Jerkins, Ph.D.,
                                                                                                                                                               solicit public comments on the
                                                                                                         Marine Safety Unit Port Arthur, U.S.                  proposed increase in LNG marine traffic
                                                Scientific Review Officer, Review Branch,
                                                                                                         Coast Guard; telephone 409–719–5086,                  on the Sabine-Neches Waterway. The
                                                DEA, NIDDK, National Institutes of Health,
                                                                                                         email Scott.K.Whalen@uscg.mil.                        Coast Guard believes that public input
                                                Room 7119, 6707 Democracy Boulevard,
                                                Bethesda, MD 20892–5452, 301–594–2242,                   SUPPLEMENTARY INFORMATION:                            may be useful to the Captain of the Port
                                                jerkinsa@niddk.nih.gov.                                                                                        Marine Safety Unit Port Arthur (COTP)
                                                                                                         I. Table of Abbreviations
                                                (Catalogue of Federal Domestic Assistance                                                                      with respect to validating the
                                                Program Nos. 93.847, Diabetes,                           CFR Code of Federal Regulations                       information provided in SPLNG’s
                                                Endocrinology and Metabolic Research;                    COTP Captain of the Port Marine                       Preliminary WSA and development of
                                                93.848, Digestive Diseases and Nutrition                   Safety Unit Port Arthur                             the LOR. A brief summary of SPLNG’s
                                                Research; 93.849, Kidney Diseases, Urology               DHS Department of Homeland                            proposal is available in the docket
                                                and Hematology Research, National Institutes               Security                                            where indicated under ADDRESSES.
                                                                                                                                                                  On January 24, 2011, the Coast Guard
sradovich on DSK3GMQ082PROD with NOTICES




                                                of Health, HHS)                                          LNG Liquefied Natural Gas
                                                                                                         LOI Letter of Intent                                  published Navigation and Vessel
                                                  Dated: July 2, 2018.
                                                                                                         LOR Letter of Recommendation                          Inspection Circular (NVIC) 01–2011,
                                                David D. Clary,                                          NVIC Navigation and Vessel                            titled ‘‘Guidance Related to Waterfront
                                                Program Analyst, Office of Federal Advisory                Inspection Circular                                 Liquefied Natural Gas (LNG) Facilities’’.
                                                Committee Policy.                                        U.S.C. United States Code                             NVIC 01–2011 provides guidance for
                                                [FR Doc. 2018–14648 Filed 7–6–18; 8:45 am]               WSA Waterway Suitability                              owners and operators seeking approval
                                                BILLING CODE 4140–01–P                                     Assessment                                          to build and operate LNG facilities. The


                                           VerDate Sep<11>2014   18:00 Jul 06, 2018   Jkt 244001   PO 00000   Frm 00049   Fmt 4703   Sfmt 4703   E:\FR\FM\09JYN1.SGM   09JYN1


                                                31764                            Federal Register / Vol. 83, No. 131 / Monday, July 9, 2018 / Notices

                                                Coast Guard will refer to NVIC 01–2011                   Malarone tablets is Canada for purposes               final determination on behalf of
                                                for process information and guidance in                  of U.S. Government procurement.                       GlaxoSmithKline LLP (‘‘GSK’’) pursuant
                                                evaluating SPLNG’s WSA. NVIC 01–                         DATES: This final determination was                   to subpart B of Part 177 of the U.S.
                                                2011 is available in the docket where                    issued on July 2, 2018. A copy of the                 Customs and Border Protection (‘‘CBP’’)
                                                indicated under ADDRESSES and also on                    final determination is attached. Any                  Regulations (19 C.F.R. Part 177). A
                                                the Coast Guard’s website at https://                    party-at-interest may seek judicial                   teleconference was held with counsel
                                                www.dco.uscg.mil/Portals/9/                              review of this final determination                    for GSK on June 8, 2018.
                                                DCO%20Documents/5p/5ps/NVIC/                             within August 8, 2018.                                   This final determination concerns the
                                                2011/NVIC%2001-2011%20Final.pdf.                         FOR FURTHER INFORMATION CONTACT: Ross                 country of origin of Malarone tablets. As
                                                IV. Public Participation and Request for                 M. Cunningham, Valuation and Special                  a U.S. importer, GSK is a party-at-
                                                Comments                                                 Programs Branch, Regulations and                      interest within the meaning of 19 C.F.R.
                                                                                                         Rulings, Office of Trade, (202) 325–                  § 177.22(d)(1) and is entitled to request
                                                   We encourage you to submit                            0034.                                                 this final determination.
                                                comments through the Federal portal at
                                                                                                         SUPPLEMENTARY INFORMATION: Notice is                  FACTS:
                                                http://www.regulations.gov. If your
                                                material cannot be submitted using                       hereby given that on July 2, 2018,
                                                                                                         pursuant to subpart B of Part 177, U.S.                  GSK is a global healthcare company
                                                http://www.regulations.gov, contact the                                                                        that researches, develops, and
                                                person in the FOR FURTHER INFORMATION                    Customs and Border Protection
                                                                                                         Regulations (19 CFR part 177, subpart                 manufactures pharmaceutical
                                                CONTACT section of this document for                                                                           medicines, vaccines, and consumer
                                                alternate instructions. In your                          B), CBP issued one final determination
                                                                                                         concerning the country of origin of                   healthcare products. At issue in this
                                                submission, please include the docket                                                                          case are tablets sold under the brand
                                                                                                         Malarone tablets, which may be offered
                                                number for this notice of inquiry and                                                                          name Malarone, which are indicated for
                                                                                                         to the U.S. Government under an
                                                provide a reason for each suggestion or                                                                        the prevention and treatment of acute,
                                                                                                         undesignated government procurement
                                                recommendation.                                                                                                uncomplicated Plasmodium falciparum
                                                                                                         contract. This final determination (HQ
                                                   We accept anonymous comments. All                                                                           malaria. GSK states that Malarone
                                                                                                         H290684) was issued under procedures
                                                comments received will be posted                                                                               tablets have been shown to be effective
                                                                                                         set forth at 19 CFR part 177, subpart B,
                                                without change to http://                                                                                      in regions where other malaria drugs
                                                                                                         which implements Title III of the Trade
                                                www.regulations.gov and will include                                                                           such as chloroquine, halofantrine,
                                                                                                         Agreements Act of 1979, as amended
                                                any personal information you have                                                                              mefloquine, and amodiaquine may have
                                                                                                         (19 U.S.C. 2511–18). In the final
                                                provided. For more about privacy and                                                                           unacceptable failure rates, presumably
                                                                                                         determination, CBP concluded that the
                                                the docket, visit http://                                                                                      due to drug resistance.
                                                                                                         processing in Canada will result in a
                                                www.regulations.gov/privacyNotice.                                                                                According to the FDA prescribing
                                                                                                         substantial transformation. Therefore,
                                                   Documents mentioned in this notice                                                                          information, Malarone is a fixed-dose
                                                                                                         the country of origin for purposes of
                                                of inquiry as being available in the                                                                           combination of atovaquone and
                                                                                                         U.S. Government procurement of the
                                                docket, and all public comments, will                                                                          proguanil hydrochloride. See
                                                                                                         Malarone tablets is Canada.
                                                be in our online docket at http://                          Section 177.29, CBP Regulations (19                Prescribing Information, https://
                                                www.regulations.gov and can be viewed                    CFR 177.29), provides that a notice of                www.fda.gov/ohrms/dockets/ac/05/
                                                by following that website’s instructions.                final determination shall be published                briefing/2005-4089b1_05_05_
                                                   This document is issued under                         in the Federal Register within 60 days                atovaquone.pdf (last visited Dec. 11,
                                                authority of 5 U.S.C. 552 (a).                           of the date the final determination is                2017). The chemical name of
                                                  Dated: July 2, 2018.                                   issued. Section 177.30, CBP Regulations               atovaquone 11 is trans-2-[4-(4
                                                Jacqueline Twomey,                                       (19 CFR 177.30), provides that any                    chlorophenyl)cyclohexyl]-3-hydroxy-
                                                Captain, U.S. Coast Guard, Captain of the                party-at-interest, as defined in 19 CFR               1,4-naphthalenedione and the molecular
                                                Port Marine Safety Unit Port Arthur.                     177.22(d), may seek judicial review of a              formula for atovaquone is C22H19ClO3.
                                                [FR Doc. 2018–14596 Filed 7–6–18; 8:45 am]               final determination within 30 days of                 The chemical name of proguanil
                                                BILLING CODE 9110–04–P                                   publication of such determination in the              hydrochloride is 1-(4-chlorophenyl)-5-
                                                                                                         Federal Register.                                     isopropyl-biguanide hydrochloride and
                                                                                                           Dated: July 2, 2018.                                the chemical formula for proguanil
                                                DEPARTMENT OF HOMELAND                                   Alice A. Kipel,                                       hydrochloride is C11H16ClN5•HCl.
                                                SECURITY                                                 Executive Director, Regulations and Rulings,          Each Malarone Tablet contains 250
                                                                                                         Office of Trade.                                      milligrams of atovaquone and 100
                                                U.S. Customs and Border Protection                                                                             milligrams of proguanil hydrochloride.
                                                                                                         HQ H290684                                               The FDA prescribing information also
                                                Notice of Issuance of Final                                                                                    describes the microbiology or
                                                                                                         July 2, 2018
                                                Determination Concerning Malarone                                                                              ‘‘mechanism of action’’ of atovaquone
                                                Tablets                                                  OT:RR:CTF:VS H290684 RMC
                                                                                                                                                               and proguanil hydrochloride. It states
                                                AGENCY:  U.S. Customs and Border                         CATEGORY: Origin                                      that atovaquone and proguanil
                                                Protection, Department of Homeland                       Nicolas Guzman                                        hydrochloride ‘‘interfere with 2
                                                Security.                                                Drinker Biddle & Reath LLP                            different pathways involved in the
                                                ACTION: Notice of final determination.                   1500 K Street NW                                      biosynthesis of pyrimidines required for
                                                                                                         Suite 1100                                            nucleic acid replication. Atovaquone is
sradovich on DSK3GMQ082PROD with NOTICES




                                                SUMMARY:   This document provides                        Washington, DC 20005–1209                             a selective inhibitor of parasite
                                                notice that U.S. Customs and Border                      Re: U.S. Government Procurement;                      mitochondrial electron transport.
                                                Protection (‘‘CBP’’) has issued a final                    Country of Origin of Malarone                       Proguanil hydrochloride primarily
                                                determination concerning the country of                    Tablets; Substantial Transformation                 exerts its effect by means of the
                                                origin of Malarone tablets. Based upon                   Dear Mr. Guzman:                                      metabolite cycloguanil, a dihydrofolate
                                                the facts presented, CBP has concluded                     This is in response to your letter,                 reductase inhibitor. Inhibition of
                                                that the country of origin of the                        dated September 13, 2017, requesting a                dihydrofolate reductase in the malaria


                                           VerDate Sep<11>2014   18:00 Jul 06, 2018   Jkt 244001   PO 00000   Frm 00050   Fmt 4703   Sfmt 4703   E:\FR\FM\09JYN1.SGM   09JYN1



Document Created: 2018-07-07 00:42:29
Document Modified: 2018-07-07 00:42:29
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of inquiry; request for comments.
DatesComments and related material must be received on or before August 8, 2018.
ContactIf you have questions about this notice of inquiry, call or email Mr. Scott K. Whalen, Vessel Traffic Service Director, Marine Safety Unit Port Arthur, U.S. Coast Guard; telephone 409-719-5086, email [email protected]
FR Citation83 FR 31763 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR